New diabetes clinical trial: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

Published on: October 10, 2022 at 11:00AM
Conditions:   Essential Hypertension;   Diabetes Mellitus, Type 2
Interventions:   Drug: ATB-1011;   Drug: ATB-1012;   Drug: ATB-1013;   Drug: ATB-1011 placebo;   Drug: ATB-1012 placebo;   Drug: ATB-1013 placebo
Sponsor:   Autotelicbio
Not yet recruiting
https://ift.tt/ef5A2ol